Mariam Priya Alexander
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mariam Priya Alexander has a total of 317 co-authors. Here are the top co-authors by number of shared publications:
Samih H. Nasr
Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA
11 shared publicationsLynn D. Cornell
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, USA
7 shared publications- Aleksandar Denic
Division of Nephrology and Hypertension, Mayo Clinic , Rochester, MN
6 shared publications Nelson Leung
Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA
6 shared publicationsSanjeev Sethi
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
6 shared publications- Andrew Bentall
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN
5 shared publications
Latest Publications
- 4 November 2025
- Published by Elsevier in Kidney International
- Vol. 109 (1) , 217-224
Dual-antigen membranous nephropathy
- 4 November 2025
- Published by Elsevier in Kidney International
- Vol. 109 (1) , 217-224
Dual-antigen membranous nephropathy
- 6 October 2025
- Published by Springer Nature
- p. 187-201
Kidney Transplant Rejection: T-Cell and Antibody-Mediated Rejection
- 6 October 2025
- Published by Springer Nature
- p. 187-201
Kidney Transplant Rejection: T-Cell and Antibody-Mediated Rejection
- Open Access
- 30 September 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (12) , 2071-2081
Spatial Mass Spectrometry-Based Proteomic Analysis of Normal-Appearing Glomeruli from Young and Old Adults
Key Points: Increased protein expression of tissue inhibitor of metalloproteinase-3, glypican 6, synuclein γ , apolipoprotein A-4, and Ecto-5′-nucleotidase was observed in old adults compared with young adults. In old adults, overexpressed proteins were enriched in mitochondrial processes while under expressed proteins enriched in RNA metabolism. Validated differentially expressed proteins were not significantly correlated with kidney pathology after adjusting for age. Background: Kidney aging is characterized by a loss of glomeruli, predominantly in the superficial cortex, with a resultant decline in GFR and an increased risk of various kidney-related diseases. The early molecular alterations in glomeruli associated with the aging process are not well studied. Methods: We combined laser capture microdissection and mass spectrometry–based unbiased proteomic analysis of nonsclerosed, nonischemic glomeruli in the superficial cortex from young and old adults who underwent a radical nephrectomy for a tumor to understand the age-related molecular changes in glomeruli. Twenty-four young and 30 old adults were used for the discovery dataset, and the significant differentially expressed proteins were further validated using an independent set comprising six young and eight old adults. Results: Kidneys from old adults had lower eGFR, less kidney parenchyma on computed tomography imaging, and more glomerulosclerosis and arteriosclerosis on histology. Quantitative proteomic analysis of nonsclerosed, nonischemic glomeruli identified increased expression of tissue inhibitor of metalloproteinase-3, glypican 6, synuclein γ , apolipoprotein A-4, and Ecto-5′-nucleotidase in old adults that were further validated in an independent set. Pathway analysis indicated that proteins with increased expression in old adults were enriched in mitochondrial translational processes, aerobic respiration, and TCA cycle, whereas proteins with decreased expression in old adults were enriched in mRNA splicing, mRNA processing, and nonsense mediated decay. Furthermore, validated differentially expressed proteins did not show any significant correlation with the kidney pathology independent of age group. Conclusions: Overall, this study identified proteins that are specifically associated with the aging process in otherwise normal-appearing glomeruli.
- 30 September 2025
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (12) , 2071-2081
Open AccessSpatial Mass Spectrometry-Based Proteomic Analysis of Normal-Appearing Glomeruli from Young and Old Adults
Key Points: Increased protein expression of tissue inhibitor of metalloproteinase-3, glypican 6, synuclein γ , apolipoprotein A-4, and Ecto-5′-nucleotidase was observed in old adults compared with young adults. In old adults, overexpressed proteins were enriched in mitochondrial processes while under expressed proteins enriched in RNA metabolism. Validated differentially expressed proteins were not significantly correlated with kidney pathology after adjusting for age. Background: Kidney aging is characterized by a loss of glomeruli, predominantly in the superficial cortex, with a resultant decline in GFR and an increased risk of various kidney-related diseases. The early molecular alterations in glomeruli associated with the aging process are not well studied. Methods: We combined laser capture microdissection and mass spectrometry–based unbiased proteomic analysis of nonsclerosed, nonischemic glomeruli in the superficial cortex from young and old adults who underwent a radical nephrectomy for a tumor to understand the age-related molecular changes in glomeruli. Twenty-four young and 30 old adults were used for the discovery dataset, and the significant differentially expressed proteins were further validated using an independent set comprising six young and eight old adults. Results: Kidneys from old adults had lower eGFR, less kidney parenchyma on computed tomography imaging, and more glomerulosclerosis and arteriosclerosis on histology. Quantitative proteomic analysis of nonsclerosed, nonischemic glomeruli identified increased expression of tissue inhibitor of metalloproteinase-3, glypican 6, synuclein γ , apolipoprotein A-4, and Ecto-5′-nucleotidase in old adults that were further validated in an independent set. Pathway analysis indicated that proteins with increased expression in old adults were enriched in mitochondrial translational processes, aerobic respiration, and TCA cycle, whereas proteins with decreased expression in old adults were enriched in mRNA splicing, mRNA processing, and nonsense mediated decay. Furthermore, validated differentially expressed proteins did not show any significant correlation with the kidney pathology independent of age group. Conclusions: Overall, this study identified proteins that are specifically associated with the aging process in otherwise normal-appearing glomeruli.
- Open Access
- 25 September 2025
- Published by BMJ in Journal of Clinical Pathology
- Vol. 79 (4) , 283-285
Fixative faux pas: glutaraldehyde’s limitation in imaging mass cytometry studies of kidney biopsies
Imaging mass cytometry (IMC) is a multiplex imaging platform allowing for the simultaneous visualisation of up to 40 different protein targets enabling in-depth studies of tissue histology within their spatial context. We have applied IMC to examine a range of kidney pathologies, including inflammation in kidney allografts,1 immune checkpoint inhibitor-associated interstitial nephritis2 and kidney disease related to COVID-19.3
- 25 September 2025
- Published by BMJ in Journal of Clinical Pathology
- Vol. 79 (4) , 283-285
Open AccessFixative faux pas: glutaraldehyde’s limitation in imaging mass cytometry studies of kidney biopsies
Imaging mass cytometry (IMC) is a multiplex imaging platform allowing for the simultaneous visualisation of up to 40 different protein targets enabling in-depth studies of tissue histology within their spatial context. We have applied IMC to examine a range of kidney pathologies, including inflammation in kidney allografts,1 immune checkpoint inhibitor-associated interstitial nephritis2 and kidney disease related to COVID-19.3
- 28 July 2025
- Published by Elsevier in Kidney International
- Vol. 108 (5) , 780-790
Management recommendations for kidney transplantation in patients with plasma cell dyscrasia
- 28 July 2025
- Published by Elsevier in Kidney International
- Vol. 108 (5) , 780-790
Management recommendations for kidney transplantation in patients with plasma cell dyscrasia
- Open Access
- 15 July 2025
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 59 (4) , 269-272
What’s new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney
Diffuse podocytopathy, including minimal change disease and primary focal segmental glomerulosclerosis, is a common cause of nephrotic syndrome in adults and children. It is increasingly recognized to be autoimmune-mediated associated with anti-nephrin and other emerging anti-slit diaphragm antibodies, and can recur in the kidney allograft. Immunofluorescence is routinely used in evaluation of kidney biopsies, and updates include those on fibrillar diseases, monoclonal staining, lupus-like staining, and use of antibody KM55 in IgA-dominant glomerulonephritis.
- 15 July 2025
- Published by The Korean Society of Pathologists and The Korean Society for Cytopathology in Journal of Pathology and Translational Medicine
- Vol. 59 (4) , 269-272
Open AccessWhat’s new in medical renal pathology 2025: Updates on podocytopathy and immunofluorescence staining in medical kidney
Diffuse podocytopathy, including minimal change disease and primary focal segmental glomerulosclerosis, is a common cause of nephrotic syndrome in adults and children. It is increasingly recognized to be autoimmune-mediated associated with anti-nephrin and other emerging anti-slit diaphragm antibodies, and can recur in the kidney allograft. Immunofluorescence is routinely used in evaluation of kidney biopsies, and updates include those on fibrillar diseases, monoclonal staining, lupus-like staining, and use of antibody KM55 in IgA-dominant glomerulonephritis.
- 8 April 2025
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 100 (5) , 776-777
Fast-Tracking Renal Failure: A Classic Case of ANCA-Associated Glomerulonephritis
- 8 April 2025
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 100 (5) , 776-777
Fast-Tracking Renal Failure: A Classic Case of ANCA-Associated Glomerulonephritis
- Open Access
- 14 December 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 78 (5) , 357-358
Sunitinib induced glomerular thrombotic microangiopathy in a patient with refractory pancreatic neuroendocrine tumour
- 14 December 2024
- Published by BMJ in Journal of Clinical Pathology
- Vol. 78 (5) , 357-358
Open AccessSunitinib induced glomerular thrombotic microangiopathy in a patient with refractory pancreatic neuroendocrine tumour
- Open Access
- 4 December 2024
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (6) , 3964-3974
Targeting mechanistic target of rapamycin complex 2 attenuates immunopathology in systemic lupus erythematosus
Objective: We aimed to explore the role of mechanistic target of rapamycin complex (mTORC) 2 in SLE development, and the in vivo regulation of mTORC2 by type I IFN signalling in autoimmunity, and to use mTORC2 targeting therapy to ameliorate lupus-like symptoms in an in vivo lupus mouse model and an in vitro co-culture model using human peripheral blood mononuclear cells (PBMCs). Method: We first induced lupus-like disease in T-cell-specific Rictor, a key component of mTORC2-deficient mice, by topical application of imiquimod (IMQ), and monitored disease development. Next, we investigated the changes in mTORC2 signalling and immunological phenotypes in type I IFNAR-deficient Lpr mice. We then tested the beneficial effects of anti-Rictor antisense oligonucleotide (Rictor-ASO) in a mouse model of lupus: MRL/lpr mice. Finally, we examined the beneficial effects of RICTOR-ASO on SLE patients’ PBMCs using an in vitro T–B co-culture assay. Results: T-cell-specific Rictor-deficient mice have reduced age-associated B cells, plasma cells and germinal centre B cells, and less autoantibody production than WT mice, following IMQ treatment. IFNAR1-deficient Lpr mice have reduced mTORC2 activity in CD4+ T cells, accompanied by restored CD4+ T cell glucose metabolism, partially recovered T cell trafficking, and reduced systemic inflammation. Rictor-ASO treatment improved renal function and pathology in MRL/lpr mice, and improved immunopathology. In a human SLE (N = 5) PBMCs derived T–B co-culture assay, RICTOR-ASO significantly reduced the production of immunoglobulin (Ig) and autoantibodies (P < 0.05). Conclusion: Targeting mTORC2 could be a promising therapeutic strategy for SLE.
- 4 December 2024
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 64 (6) , 3964-3974
Open AccessTargeting mechanistic target of rapamycin complex 2 attenuates immunopathology in systemic lupus erythematosus
Objective: We aimed to explore the role of mechanistic target of rapamycin complex (mTORC) 2 in SLE development, and the in vivo regulation of mTORC2 by type I IFN signalling in autoimmunity, and to use mTORC2 targeting therapy to ameliorate lupus-like symptoms in an in vivo lupus mouse model and an in vitro co-culture model using human peripheral blood mononuclear cells (PBMCs). Method: We first induced lupus-like disease in T-cell-specific Rictor, a key component of mTORC2-deficient mice, by topical application of imiquimod (IMQ), and monitored disease development. Next, we investigated the changes in mTORC2 signalling and immunological phenotypes in type I IFNAR-deficient Lpr mice. We then tested the beneficial effects of anti-Rictor antisense oligonucleotide (Rictor-ASO) in a mouse model of lupus: MRL/lpr mice. Finally, we examined the beneficial effects of RICTOR-ASO on SLE patients’ PBMCs using an in vitro T–B co-culture assay. Results: T-cell-specific Rictor-deficient mice have reduced age-associated B cells, plasma cells and germinal centre B cells, and less autoantibody production than WT mice, following IMQ treatment. IFNAR1-deficient Lpr mice have reduced mTORC2 activity in CD4+ T cells, accompanied by restored CD4+ T cell glucose metabolism, partially recovered T cell trafficking, and reduced systemic inflammation. Rictor-ASO treatment improved renal function and pathology in MRL/lpr mice, and improved immunopathology. In a human SLE (N = 5) PBMCs derived T–B co-culture assay, RICTOR-ASO significantly reduced the production of immunoglobulin (Ig) and autoantibodies (P < 0.05). Conclusion: Targeting mTORC2 could be a promising therapeutic strategy for SLE.
- 18 September 2024
- Published by Elsevier in Kidney International
- Vol. 106 (6) , 1062-1071
Clonal monocytosis of renal significance
- 18 September 2024
- Published by Elsevier in Kidney International
- Vol. 106 (6) , 1062-1071
Clonal monocytosis of renal significance